Cilastatin does not alter superoxide dismutase activity
- PMID: 3867330
- PMCID: PMC176359
- DOI: 10.1128/AAC.28.5.691
Cilastatin does not alter superoxide dismutase activity
Abstract
Cilastatin inhibits dehydropeptidase-I, a zinc metaloenzyme that metabolizes imipenem. Because zinc stabilizes the mammalian superoxide dismutase, we postulated that cilastatin would also inhibit the dismutase. Cilastatin concentrations at levels threefold higher than those expected in urine, however, did not inhibit the superoxide dismutase activity.
Similar articles
-
[Do imipenem and cilastatin interfere with the determination of serum creatinine?].Pathol Biol (Paris). 1988 May;36(5):511-2. Pathol Biol (Paris). 1988. PMID: 3043349 French.
-
Stimulation of granulocyte functions in vitro by imipenem and the renal enzyme inhibitor MK 0791.Antimicrob Agents Chemother. 1984 Feb;25(2):179-81. doi: 10.1128/AAC.25.2.179. Antimicrob Agents Chemother. 1984. PMID: 6585179 Free PMC article.
-
Imipenem/cilastatin: the first carbapenem antibiotic.Drug Intell Clin Pharm. 1985 Dec;19(12):895-9. Drug Intell Clin Pharm. 1985. PMID: 3910385 Review.
-
Nephroprotective effect of imipenem/cilastatin in reducing cyclosporine toxicity.Transplant Proc. 1987 Feb;19(1 Pt 2):1755-8. Transplant Proc. 1987. PMID: 3469804 No abstract available.
-
An overview of the pharmacology of imipenem/cilastatin.J Antimicrob Chemother. 1986 Dec;18 Suppl E:79-92. doi: 10.1093/jac/18.supplement_e.79. J Antimicrob Chemother. 1986. PMID: 3546249 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources